Ineffectiveness of rat liver tissues in the screening of connective tissue disease

Saudi Medical Journal

Volumn 25, Issue 4, 2004, Pages 442-446

  Aziz, Khalil A ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; DNA ANTIBODY; DOUBLE STRANDED DNA; RO ANTIBODY;

ANIMAL TISSUE; ANTIBODY SCREENING; ARTICLE; CLINICAL LABORATORY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER EXAMINATION; NONHUMAN; RAT; SCREENING TEST; UNITED KINGDOM;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; HUMANS; LIVER; RATS; RETROSPECTIVE STUDIES;

EID: 2342653446     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Swaak AJ, Huysen V, Smeenk RJ. Antinuclear antibodies in routine analysis: the relevance of putative clinical association. Ann Rheum Dis 1993; 52: 110-114.
2. Hollingsworth PN, Pummer SC, Dawkins RL. Antinuclear antibodies. In: Peter PN, Shoenfield Y, editors. Autoantibodies. 1st ed. Amsterdam (NE): Elsevier Science BV; 1996. p. 74-90.
3. White RH, Robbins DL. Clinical significance and interpretation of antinuclear antibodies. West J Med 1987; 147: 210-213.
4. Homurger HA. Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc 1995; 70: 183-184.
5. Feltkamp TEW, Klein F, Janssens MB. Standardization of the quantitative determination of antinuclear antibodies (ANAs) with a homogenous pattern. Ann Rheum Dis 1988; 47: 906-909.
6. Fritzler MJ, Kinsella TD. The CREST syndrome: a distinct serological entity with anticentromere antibodies. Am J Med 1980; 69: 520-526.
7. Reimer G, Steen VM, Penning CA. Correlates between autoantibodies to nucleaoler antigen and clinical features in patients with systemic sclerosis (Scleroderma). Arthritis Rheum 1988; 31: 525-532.
8. Kozin F, Fowler M, Koethe SM. A comparison of the sensitivities and specificities of different substrate for the fluorescent anti-nuclear antibody test. Am J Clin Pathol 1980: 74: 785-790.
9. Hormon CE, Deng J, Peebles CL, Tan EM. The importance of tissue substrate in the SS-A/Ro antigen-antibody system. Arthritis Rheum 1984; 27: 166-173.
10. Spickett G. Oxford Handbook of Clinical Immunology. Oxford (UK): Oxford University Press; 1999.
11. Isenberg DA, Dudeney C, Wailliams W, Addison I, Charles C, Clark L. Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 1987; 46: 448-456.
12. Ehrensten MR. Antinuclear antibodies and lupus: causes and consequences. Rheumatology 1999; 38: 691-696.
13. Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjoholm A, Strfeld G et al. Complement activation in patients with systemic lupus erythematosus without nephritis. Rheumatology 1999; 38: 933-940.
14. Davidson BKS, Kelly CA, Griffiths ID. Primary Sjogren's syndrome in the north of England: a long-term follow up. Rheumatology 1999; 38: 245-253.
15. Ho A, Magder LS, Barr SB, Petri M. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2342-2349.
16. Roben P, Barbas SB, Sandoval L, Lecerf JM, Stollar BD, Solomon A. Repertoire cloning of lupus anti-DNA autoantibodies. J Clin Invest 1996; 98: 2827-2837.
17. Barbas SM, Ditzel HJ, Salonen EM, Wang WP, Sliverman GJ, Burton DR. Human antibody recognition of DNA. Proc Natl Acad Sci USA 1995; 92: 2529-2533.
18. Harely JB, Alxander EL, Bias WB, Fox OF, Provost T, Reichlin M et al. Anti Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum 1986; 29: 196-206.